在筛查恶性高热患者中评估肌酸磷酸激酶。
Evaluation of creatinine phosphokinase in screening patients for malignant hyperpyrexia.
作者信息
Ellis F R, Clarke I M, Modgill M, Currie S, Harriman D G
出版信息
Br Med J. 1975 Aug 30;3(5982):511-3. doi: 10.1136/bmj.3.5982.511.
Abstract
Evidence is presented that serum creatinine phosphokinase (CPK) activity is of no direct value in screening patients for susceptibility to malignant hyperpyrexia and does not correlate with halothane-induced muscle contracture or the presence of myopathy. Widely differing CPK values were found at different times in the same people. In most "malignant hyperpyrexia" families the susceptible patients had either normal or inconsistently raised CPK values.
摘要
有证据表明，血清肌酸磷酸激酶（CPK）活性在筛查患者对恶性高热的易感性方面没有直接价值，并且与氟烷诱导的肌肉挛缩或肌病的存在无关。在同一人群的不同时间发现了差异很大的CPK值。在大多数“恶性高热”家族中，易感患者的CPK值要么正常，要么不一致地升高。
相似文献
1
Evaluation of creatinine phosphokinase in screening patients for malignant hyperpyrexia.在筛查恶性高热患者中评估肌酸磷酸激酶。
Br Med J. 1975 Aug 30;3(5982):511-3. doi: 10.1136/bmj.3.5982.511.
2
Screening of malignant hyperthermia susceptible families by creatine phosphokinase measurement and other clinical investigations.
Can Anaesth Soc J. 1976 May;23(3):263-84. doi: 10.1007/BF03005702.
3
Creatine phosphokinase (CPK) levels in pregnancy: a case report and a discussion of the value of CPK levels in the prediction of possible malignant hyperpyrexia.孕期肌酸磷酸激酶（CPK）水平：一例病例报告及CPK水平在预测可能的恶性高热中的价值探讨
Br J Obstet Gynaecol. 1975 Apr;82(4):346-9. doi: 10.1111/j.1471-0528.1975.tb00647.x.
4
Identification of susceptibility to malignant hyperpyrexia.恶性高热易感性的鉴定。
Br Med J. 1974 May 4;2(5913):245-7. doi: 10.1136/bmj.2.5913.245.
5
Masseter muscle rigidity and malignant hyperthermia susceptibility.咬肌强直与恶性高热易感性。
Anesth Analg. 1986 Feb;65(2):161-4.
6
A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group.恶性高热（MH）易感性调查方案。欧洲恶性高热研究小组。
Br J Anaesth. 1984 Nov;56(11):1267-9. doi: 10.1093/bja/56.11.1267.
7
Screening for malignant hyperpyrexia.恶性高热筛查。
Br Med J. 1972 Sep 2;3(5826):559-61. doi: 10.1136/bmj.3.5826.559.
8
Malignant hyperpyrexia.
Anaesthesia. 1973 May;28(3):245-52.
9
Diagnostic value of serum creatine phosphokinase activity for the porcine malignant hyperthermia syndrome.
Anesth Analg. 1975 Jul-Aug;54(4):536-9. doi: 10.1213/00000539-197507000-00028.
10
Isoenzymes of creatine phosphokinase in serum of families with malignant hyperpyrexia.恶性高热家族血清中肌酸磷酸激酶的同工酶
Anesth Analg. 1976 Nov-Dec;55(6):797-9. doi: 10.1213/00000539-197611000-00010.
引用本文的文献
1
Malignant hyperthermia.恶性高热
Korean J Anesthesiol. 2012 Nov;63(5):391-401. doi: 10.4097/kjae.2012.63.5.391. Epub 2012 Nov 16.
2
Erythrocyte osmotic fragility testing and the prediction of canine malignant hyperthermia susceptibility.红细胞渗透脆性测试与犬恶性高热易感性的预测
Can Vet J. 1986 Dec;27(12):517-22.
3
Adverse effects of drugs on muscle.药物对肌肉的不良反应。
Drugs. 1982 Oct;24(4):304-21. doi: 10.2165/00003495-198224040-00003.
4
The anaesthetic management of the malignant hyperthermia susceptible parturient.恶性高热易感产妇的麻醉管理
Can Anaesth Soc J. 1986 May;33(3 Pt 1):371-8. doi: 10.1007/BF03010752.
5
[A case of malignant hyperthermia occuring in a dental clinic].[牙科诊所发生恶性高热一例]
Can Anaesth Soc J. 1979 Jan;26(1):55-7. doi: 10.1007/BF03039455.
本文引用的文献
1
Malignant hyperpyrexia myopathy.恶性高热性肌病
Q J Med. 1973 Oct;42(168):639-64.
2
Malignant hyperthermia: a statistical review.恶性高热：一项统计学综述。
Can Anaesth Soc J. 1970 Jul;17(4):293-315. doi: 10.1007/BF03004694.
Zotero 插件